Author Correction: Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonists
Arun Chandramohan, Hubert Josien, Tsz Ying Yuen, Ruchia Duggal, Diana Spiegelberg, Lin Yan, Yu-Chi Angela Juang, Lan Ge, Pietro G. Aronica, Hung Yi Kristal Kaan, Yee Hwee Lim, Andrea Peier, Brad Sherborne, Jerome Hochman, Songnian Lin, Kaustav Biswas, Marika Nestor
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsReceptor Mechanisms and Signaling
Correction to: Nature Communications 10.1038/s41467-023-43346-4, published online 12 January 2024
In the version of the article initially published, in the “Selection of staple position” section of the Discussion, the sentence “Although many staple types exist, our suggestion is to limit the initial analogs to a single chemistry: olefin staples resulting from ring closing metathesis of (S)-2-(4’-pentenyl)alanine and (R)-2-(7’-octenyl)alanine at the i and i + 7 positions, respectively” should have read “Although many staple types exist, our suggestion is to limit the initial analogs to a single chemistry: olefin staples resulting from ring closing metathesis of (R)-2-(7’-octenyl)alanine and (S)-2-(4’-pentenyl)alanine at the i and i + 7 positions, respectively” and has now been corrected in the HTML and PDF versions of the article.